目次

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Study Design
1.2.2. Indication
1.2.3. Indication by Study Design
1.2.4. Indication by Phase
1.2.5. Value Chain
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Neurology Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of neurological diseases such as Alzheimer disease, epilepsy, and stroke
3.2.1.2. Growing adoption of novel technologies in clinical research
3.2.1.3. Substantial number of CROs providing neurology clinical research services
3.2.1.4. Increasing funding for neurological studies by public organizations
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with neurology clinical studies
3.2.2.2. High failure rate coupled with patient dropout issues associated with neurological clinical trials
3.2.3. Market Challenges
3.2.4. Market Opportunities
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. R&D Spending Analysis (2018-2024)
3.6. Clinical Trial Volume Analysis, 2024
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
3.7.3. COVID-19 Impact Analysis

Chapter 4. Neurology Clinical Trials Market: Phase Estimates & Trend Analysis
4.1. Neurology Clinical Trials Market, By Phase: Segment Dashboard
4.2. Neurology Clinical Trials Market, By Phase: Movement Analysis
4.3. Neurology Clinical Trials Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million)
4.4. Phase I
4.4.1. Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Phase II
4.5.1. Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Phase III
4.6.1. Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Phase IV
4.7.1. Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurology Clinical Trials Market: Study Design Estimates & Trend Analysis
5.1. Neurology Clinical Trials Market, By Study Design: Segment Dashboard
5.2. Neurology Clinical Trials Market, By Study Design: Movement Analysis
5.3. Neurology Clinical Trials Market Estimates & Forecasts, By Study Design, 2018 - 2030 (USD Million)
5.4. Interventional
5.4.1. Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Observational
5.5.1. Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Expanded Access
5.6.1. Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurology Clinical Trials Market: Indication Estimates & Trend Analysis
6.1. Neurology Clinical Trials Market, By Indication: Segment Dashboard
6.2. Neurology Clinical Trials Market, By Indication: Movement Analysis
6.3. Neurology Clinical Trials Market Estimates & Forecasts, By Indication, 2018 - 2030 (USD Million)
6.4. Alzheimer’s Disease
6.4.1. Alzheimer’s Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Depression (MDD)
6.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Parkinson's Disease (PD)
6.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Epilepsy
6.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Stroke
6.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Traumatic Brain Injury (TBI)
6.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Amyotrophic Lateral Sclerosis (ALS)
6.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Huntington's Disease
6.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.12. Muscle Regeneration
6.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.13. Others
6.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Neurology Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis
7.1. Neurology Clinical Trials Market, Indication by Study Design: Segment Dashboard
7.2. Neurology Clinical Trials Market, Indication by Study Design: Movement Analysis
7.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Study Design, 2018 - 2030 (USD Million)
7.4. Alzheimer’s Disease
7.4.1. Alzheimer’s Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Alzheimer’s Disease Interventional
7.4.2.1. Alzheimer’s Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Alzheimer’s Disease Observational
7.4.3.1. Alzheimer’s Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Alzheimer’s Disease Expanded Access
7.4.4.1. Alzheimer’s Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Depression (MDD)
7.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Depression (MDD) Interventional
7.5.2.1. Depression (MDD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Depression (MDD) Observational
7.5.3.1. Depression (MDD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Depression (MDD) Expanded Access
7.5.4.1. Depression (MDD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Parkinson’s Disease (PD)
7.6.1. Parkinson’s Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Parkinson’s Disease (PD) Interventional
7.6.2.1. Parkinson’s Disease (PD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Parkinson’s Disease (PD) Observational
7.6.3.1. Parkinson’s Disease (PD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. Parkinson’s Disease (PD) Expanded Access
7.6.4.1. Parkinson’s Disease (PD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Epilepsy
7.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Epilepsy Interventional
7.7.2.1. Epilepsy Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Epilepsy Observational
7.7.3.1. Epilepsy Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4. Epilepsy Expanded Access
7.7.4.1. Epilepsy Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Stroke
7.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. Stroke Interventional
7.8.2.1. Stroke Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Stroke Observational
7.8.3.1. Stroke Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. Stroke Expanded Access
7.8.4.1. Stroke Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Traumatic Brain Injury (TBI)
7.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.2. Traumatic Brain Injury (TBI) Interventional
7.9.2.1. Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.3. Traumatic Brain Injury (TBI) Observational
7.9.3.1. Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.4. Traumatic Brain Injury (TBI) Expanded Access
7.9.4.1. Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Amyotrophic Lateral Sclerosis (ALS)
7.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.2. Amyotrophic Lateral Sclerosis (ALS) Interventional
7.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.3. Amyotrophic Lateral Sclerosis (ALS) Observational
7.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.4. Amyotrophic Lateral Sclerosis (ALS) Expanded Access
7.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11. Huntington’s Disease
7.11.1. Huntington’s Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.2. Huntington’s Disease Interventional
7.11.2.1. Huntington’s Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.3. Huntington’s Disease Observational
7.11.3.1. Huntington’s Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.4. Huntington’s Disease Expanded Access
7.11.4.1. Huntington’s Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.12. Muscle Regeneration
7.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.12.2. Muscle Regeneration Interventional
7.12.2.1. Muscle Regeneration Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.12.3. Muscle Regeneration Observational
7.12.3.1. Muscle Regeneration Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.12.4. Muscle Regeneration Expanded Access
7.12.4.1. Muscle Regeneration Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.13. Others
7.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.13.2. Others Interventional
7.13.2.1. Others Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.13.3. Others Observational
7.13.3.1. Others Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.13.4. Others Expanded Access
7.13.4.1. Others Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Neurology Clinical Trials Market: Indication by Phase Estimates & Trend Analysis
8.1. Neurology Clinical Trials Market, Indication by Phase: Segment Dashboard
8.2. Neurology Clinical Trials Market, Indication by Phase: Movement Analysis
8.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Phase, 2018 - 2030 (USD Million)
8.4. Alzheimer’s Disease
8.4.1. Alzheimer’s Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Alzheimer’s Disease Phase I
8.4.2.1. Alzheimer’s Disease Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Alzheimer’s Disease Phase II
8.4.3.1. Alzheimer’s Disease Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. Alzheimer’s Disease Phase III
8.4.4.1. Alzheimer’s Disease Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Alzheimer’s Disease Phase IV
8.4.5.1. Alzheimer’s Disease Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Depression (MDD)
8.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Depression (MDD) Phase I
8.5.2.1. Depression (MDD) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Depression (MDD) Phase II
8.5.3.1. Depression (MDD) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.4. Depression (MDD) Phase III
8.5.4.1. Depression (MDD) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.5. Depression (MDD) Phase IV
8.5.5.1. Depression (MDD) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Parkinson's Disease (PD)
8.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Parkinson's Disease (PD) Phase I
8.6.2.1. Parkinson's Disease (PD) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Parkinson's Disease (PD) Phase II
8.6.3.1. Parkinson's Disease (PD) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. Parkinson's Disease (PD) Phase III
8.6.4.1. Parkinson's Disease (PD) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Parkinson's Disease (PD) Phase IV
8.6.5.1. Parkinson's Disease (PD) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Epilepsy
8.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.2. Epilepsy Phase I
8.7.2.1. Epilepsy Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.3. Epilepsy Phase II
8.7.3.1. Epilepsy Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.4. Epilepsy Phase III
8.7.4.1. Epilepsy Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.5. Epilepsy Phase IV
8.7.5.1. Epilepsy Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Stroke
8.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.2. Stroke Phase I
8.8.2.1. Stroke Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.3. Stroke Phase II
8.8.3.1. Stroke Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.4. Stroke Phase III
8.8.4.1. Stroke Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8.5. Stroke Phase IV
8.8.5.1. Stroke Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9. Traumatic Brain Injury (TBI)
8.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9.2. Traumatic Brain Injury (TBI) Phase I
8.9.2.1. Traumatic Brain Injury (TBI) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9.3. Traumatic Brain Injury (TBI) Phase II
8.9.3.1. Traumatic Brain Injury (TBI) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9.4. Traumatic Brain Injury (TBI) Phase III
8.9.4.1. Traumatic Brain Injury (TBI) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9.5. Traumatic Brain Injury (TBI) Phase IV
8.9.5.1. Traumatic Brain Injury (TBI) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.10. Amyotrophic Lateral Sclerosis (ALS)
8.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.10.2. Amyotrophic Lateral Sclerosis (ALS) Phase I
8.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.10.3. Amyotrophic Lateral Sclerosis (ALS) Phase II
8.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.10.4. Amyotrophic Lateral Sclerosis (ALS) Phase III
8.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.10.5. Amyotrophic Lateral Sclerosis (ALS) Phase IV
8.10.5.1. Amyotrophic Lateral Sclerosis (ALS) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.11. Huntington's Disease
8.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.11.2. Huntington's Disease Phase I
8.11.2.1. Huntington's Disease Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.11.3. Huntington's Disease Phase II
8.11.3.1. Huntington's Disease Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.11.4. Huntington's Disease Phase III
8.11.4.1. Huntington's Disease Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.11.5. Huntington's Disease Phase IV
8.11.5.1. Huntington's Disease Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.12. Muscle Regeneration
8.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.12.2. Muscle Regeneration Phase I
8.12.2.1. Muscle Regeneration Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.12.3. Muscle Regeneration Phase II
8.12.3.1. Muscle Regeneration Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.12.4. Muscle Regeneration Phase III
8.12.4.1. Muscle Regeneration Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.12.5. Muscle Regeneration Phase IV
8.12.5.1. Muscle Regeneration Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.13. Others
8.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.13.2. Others Phase I
8.13.2.1. Others Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.13.3. Others Phase II
8.13.3.1. Others Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.13.4. Others Phase III
8.13.4.1. Others Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.13.5. Others Phase IV
8.13.5.1. Others Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Neurology Clinical Trials Market: Value Chain Estimates & Trend Analysis
9.1. Neurology Clinical Trials Market, By Value Chain: Segment Dashboard
9.2. Neurology Clinical Trials Market, By Value Chain: Movement Analysis
9.3. Neurology Clinical Trials Market Estimates & Forecasts, By Value Chain, 2018 - 2030 (USD Million)
9.4. In-house
9.4.1. In-house Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. CROs
9.5.1. CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Investigator Sites/Clinical Sites
9.6.1. Investigator Sites/Clinical Sites Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Neurology Clinical Trials Market: Regional Estimates & Trend Analysis
10.1. Regional Market Dashboard
10.2. Regional Market Share Analysis, 2024 & 2030
10.3. North America
10.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.3.2. U.S
10.3.2.1. Key Country Dynamics
10.3.2.2. Competitive Scenario
10.3.2.3. Regulatory Framework
10.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.3.3. Canada
10.3.3.1. Key Country Dynamics
10.3.3.2. Competitive Scenario
10.3.3.3. Regulatory Framework
10.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.3.4. Mexico
10.3.4.1. Key Country Dynamics
10.3.4.2. Competitive Scenario
10.3.4.3. Regulatory Framework
10.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4. Europe
10.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.2. UK
10.4.2.1. Key Country Dynamics
10.4.2.2. Competitive Scenario
10.4.2.3. Regulatory Framework
10.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.3. Germany
10.4.3.1. Key Country Dynamics
10.4.3.2. Competitive Scenario
10.4.3.3. Regulatory Framework
10.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.4. France
10.4.4.1. Key Country Dynamics
10.4.4.2. Competitive Scenario
10.4.4.3. Regulatory Framework
10.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.5. Italy
10.4.5.1. Key Country Dynamics
10.4.5.2. Competitive Scenario
10.4.5.3. Regulatory Framework
10.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.6. Spain
10.4.6.1. Key Country Dynamics
10.4.6.2. Competitive Scenario
10.4.6.3. Regulatory Framework
10.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.7. Denmark
10.4.7.1. Key Country Dynamics
10.4.7.2. Competitive Scenario
10.4.7.3. Regulatory Framework
10.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.8. Sweden
10.4.8.1. Key Country Dynamics
10.4.8.2. Competitive Scenario
10.4.8.3. Regulatory Framework
10.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.9. Norway
10.4.9.1. Key Country Dynamics
10.4.9.2. Competitive Scenario
10.4.9.3. Regulatory Framework
10.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5. Asia Pacific
10.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.2. Japan
10.5.2.1. Key Country Dynamics
10.5.2.2. Competitive Scenario
10.5.2.3. Regulatory Framework
10.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.3. China
10.5.3.1. Key Country Dynamics
10.5.3.2. Competitive Scenario
10.5.3.3. Regulatory Framework
10.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.4. India
10.5.4.1. Key Country Dynamics
10.5.4.2. Competitive Scenario
10.5.4.3. Regulatory Framework
10.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.5. Thailand
10.5.5.1. Key Country Dynamics
10.5.5.2. Competitive Scenario
10.5.5.3. Regulatory Framework
10.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.6. South Korea
10.5.6.1. Key Country Dynamics
10.5.6.2. Competitive Scenario
10.5.6.3. Regulatory Framework
10.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.7. Australia
10.5.7.1. Key Country Dynamics
10.5.7.2. Competitive Scenario
10.5.7.3. Regulatory Framework
10.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.6. Latin America
10.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.2. Brazil
10.6.2.1. Key Country Dynamics
10.6.2.2. Competitive Scenario
10.6.2.3. Regulatory Framework
10.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.3. Argentina
10.6.3.1. Key Country Dynamics
10.6.3.2. Competitive Scenario
10.6.3.3. Regulatory Framework
10.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7. MEA
10.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.2. South Africa
10.7.2.1. Key Country Dynamics
10.7.2.2. Competitive Scenario
10.7.2.3. Regulatory Framework
10.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.3. Saudi Arabia
10.7.3.1. Key Country Dynamics
10.7.3.2. Competitive Scenario
10.7.3.3. Regulatory Framework
10.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.4. UAE
10.7.4.1. Key Country Dynamics
10.7.4.2. Competitive Scenario
10.7.4.3. Regulatory Framework
10.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.5. Kuwait
10.7.5.1. Key Country Dynamics
10.7.5.2. Competitive Scenario
10.7.5.3. Regulatory Framework
10.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape
11.1. Participant Categorization
11.2. Market Position Analysis, 2024 (Heat Map Analysis)
11.3. Company Profiles
11.3.1. Novartis
11.3.1.1. Company Overview
11.3.1.2. Financial Performance
11.3.1.3. Service Benchmarking
11.3.1.4. Strategic Initiatives
11.3.2. IQVIA
11.3.2.1. Company Overview
11.3.2.2. Financial Performance
11.3.2.3. Service Benchmarking
11.3.2.4. Strategic Initiatives
11.3.3. F. Hoffmann-La Roche Ltd.
11.3.3.1. Company Overview
11.3.3.2. Financial Performance
11.3.3.3. Service Benchmarking
11.3.3.4. Strategic Initiatives
11.3.4. Medpace
11.3.4.1. Company Overview
11.3.4.2. Financial Performance
11.3.4.3. Service Benchmarking
11.3.4.4. Strategic Initiatives
11.3.5. Charles River Laboratories
11.3.5.1. Company Overview
11.3.5.2. Financial Performance
11.3.5.3. Service Benchmarking
11.3.5.4. Strategic Initiatives
11.3.6. Syneos Health
11.3.6.1. Company Overview
11.3.6.2. Financial Performance
11.3.6.3. Service Benchmarking
11.3.6.4. Strategic Initiatives
11.3.7. Icon Plc
11.3.7.1. Company Overview
11.3.7.2. Financial Performance
11.3.7.3. Service Benchmarking
11.3.7.4. Strategic Initiatives
11.3.8. Lindus Health
11.3.8.1. Company Overview
11.3.8.2. Financial Performance
11.3.8.3. Service Benchmarking
11.3.8.4. Strategic Initiatives
11.3.9. AbbVie
11.3.9.1. Company Overview
11.3.9.2. Financial Performance
11.3.9.3. Service Benchmarking
11.3.9.4. Strategic Initiatives
11.3.10. GlaxoSmithKline
11.3.10.1. Company Overview
11.3.10.2. Financial Performance
11.3.10.3. Service Benchmarking
11.3.10.4. Strategic Initiatives
11.3.11. Aurora healthcare
11.3.11.1. Company Overview
11.3.11.2. Financial Performance
11.3.11.3. Service Benchmarking
11.3.11.4. Strategic Initiatives
11.3.12. Labcorp Drug Development
11.3.12.1. Company Overview
11.3.12.2. Financial Performance
11.3.12.3. Service Benchmarking
11.3.12.4. Strategic Initiatives
11.3.13. Pfizer
11.3.13.1. Company Overview
11.3.13.2. Financial Performance
11.3.13.3. Service Benchmarking
11.3.13.4. Strategic Initiatives
11.3.14. AstraZeneca
11.3.14.1. Company Overview
11.3.14.2. Financial Performance
11.3.14.3. Service Benchmarking
11.3.14.4. Strategic Initiatives
11.3.15. Biogen
11.3.15.1. Company Overview
11.3.15.2. Financial Performance
11.3.15.3. Service Benchmarking
11.3.15.4. Strategic Initiatives
11.3.16. Eli Lilly
11.3.16.1. Company Overview
11.3.16.2. Financial Performance
11.3.16.3. Service Benchmarking
11.3.16.4. Strategic Initiatives
11.3.17. Alzheon
11.3.17.1. Company Overview
11.3.17.2. Financial Performance
11.3.17.3. Service Benchmarking
11.3.17.4. Strategic Initiatives
11.3.18. GAP Network
11.3.18.1. Company Overview
11.3.18.2. Financial Performance
11.3.18.3. Service Benchmarking
11.3.18.4. Strategic Initiatives
11.3.19. BDD Pharma
11.3.19.1. Company Overview
11.3.19.2. Financial Performance
11.3.19.3. Service Benchmarking
11.3.19.4. Strategic Initiatives
11.3.20. Re:Cognition Health
11.3.20.1. Company Overview
11.3.20.2. Financial Performance
11.3.20.3. Service Benchmarking
11.3.20.4. Strategic Initiatives

Chapter 12 Key Recommendations

List of Tables
Table 1. List of Tables
Table 2. List of Secondary Sources
Table 3. List of Abbreviations
Table 4. Global Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 5. Global Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 6. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 7. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 8. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 9. Global Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 10. Global Neurology Clinical Trials Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
Table 11. North America Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 12. North America Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 13. North America Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 14. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 15. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 16. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 17. North America Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 18. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 19. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 20. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 21. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 22. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 23. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 24. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 25. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 26. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 27. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 28. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 29. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 30. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 31. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 32. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 33. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 34. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 35. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 36. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 37. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 38. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 39. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 40. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 41. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 42. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 43. UK Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 44. UK Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 45. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 46. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 47. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 48. UK Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 49. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 50. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 51. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 52. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 53. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 54. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 55. France Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 56. France Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 57. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 58. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 59. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 60. France Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 61. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 62. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 63. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 64. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 65. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 66. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 67. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 68. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 69. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 70. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 71. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 72. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 73. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 74. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 75. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 76. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 77. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 78. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 79. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 80. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 81. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 82. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 83. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 84. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 85. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 86. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 87. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 88. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 89. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 90. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 91. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 92. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 93. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 94. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 95. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 96. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 97. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 98. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 99. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 100. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 101. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 102. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 103. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 104. China Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 105. China Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 106. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 107. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 108. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 109. China Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 110. India Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 111. India Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 112. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 113. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 114. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 115. India Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 116. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 117. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 118. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 119. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 120. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 121. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 122. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 123. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 124. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 125. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 126. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 127. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 128. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 129. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 130. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 131. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 132. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 133. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 134. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 135. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 136. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 137. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 138. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 139. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 140. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 141. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 142. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 143. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 144. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 145. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 146. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 147. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 148. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 149. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 150. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 151. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 152. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 153. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 154. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 155. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 156. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 157. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 158. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 159. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 160. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 161. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 162. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 163. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 164. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 165. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 166. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 167. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 168. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 169. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 170. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 171. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 172. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 173. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 174. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 175. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
Table 176. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
Table 177. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
Table 178. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
Table 179. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
Table 180. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
Table 181. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 Neurology Clinical Trials Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Neurology Clinical Trials Market: Phase outlook and key takeaways
Fig. 20 Neurology Clinical Trials Market: Phase movement analysis
Fig. 21 Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 22 Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 23 Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 24 Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 25 Neurology Clinical Trials Market: Study design outlook and key takeaways
Fig. 26 Neurology Clinical Trials Market: Study design movement analysis
Fig. 27 Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 28 Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 29 Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 30 Neurology Clinical Trials Market: Indication outlook and key takeaways
Fig. 31 Neurology Clinical Trials Market: Indication movement analysis
Fig. 32 Alzheimer’s Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 33 Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 34 Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 35 Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 36 Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 37 Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 38 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 39 Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 40 Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 42 Neurology Clinical Trials Market: Indication by Study Design outlook and key takeaways
Fig. 43 Neurology Clinical Trials Market: Indication by Study Design movement analysis
Fig. 44 Alzheimer’s Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Alzheimer’s Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Alzheimer’s Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Depression (MDD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 48 Depression (MDD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 Depression (MDD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 Parkinson's Disease (PD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 51 Parkinson's Disease (PD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Parkinson's Disease (PD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 53 Epilepsy Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Epilepsy Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 Epilepsy Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Stroke Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 57 Stroke Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Stroke Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 59 Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 Huntington's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 Huntington's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 67 Huntington's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Muscle Regeneration Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 Muscle Regeneration Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Muscle Regeneration Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 71 Others Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 72 Others Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 73 Others Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 74 Neurology Clinical Trials Market: Value Chain Design outlook and key takeaways
Fig. 75 Neurology Clinical Trials Market: Value Chain movement analysis
Fig. 76 In-house Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 77 CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 78 Investigator Sites/Clinical Sites Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 79 Regional Marketplace: Key Takeaways
Fig. 80 North America Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 U.S. Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Canada Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Mexico Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 87 Europe Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 UK Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Germany Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 France Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Italy Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Spain Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Denmark Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Sweden Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Norway Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 104 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 Japan Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 China Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 India Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Thailand Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 113 Key country dynamics
Fig. 114 South Korea Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 115 Key country dynamics
Fig. 116 Australia Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 117 Latin America Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 118 Key country dynamics
Fig. 119 Brazil Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 120 Key country dynamics
Fig. 121 Argentina Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 122 MEA Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 123 Key country dynamics
Fig. 124 South Africa Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 125 Key country dynamics
Fig. 126 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 127 Key country dynamics
Fig. 128 UAE Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 129 Key country dynamics
Fig. 130 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 131 Key company categorization
Fig. 132 Service heat map analysis
Fig. 133 Strategic framework